Northwest & Ethical Investments L.P.
Position in GILD — Gilead Sciences, Inc.
CIK 2033536
TORONTO, A6
Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$37,230,502
-$11,130,191 QoQ
Shares Held
294,685
-15.1% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#247
of 2,266 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Northwest & Ethical Investments L.P. holds $150,710,322 across 7 Drug Manufacturers - General names. GILD ranks #2 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
311,108 | $39,977,378 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
294,685 | $37,230,502 | |
| 3 | LLY |
ELI LILLY & Co
|
27,350 | $32,804,413 | |
| 4 | ABBV |
AbbVie Inc.
|
118,057 | $29,707,863 | |
| 5 | PFE |
Pfizer Inc
|
221,058 | $5,323,076 | |
| 6 | JNJ |
Johnson & Johnson
|
20,023 | $5,085,241 | |
| 7 | BIIB |
Biogen Inc.
|
2,693 | $581,849 |
All Filings in GILD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,230,502 | 294,685 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $48,360,693 | 346,995 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $40,284,127 | 328,207 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $35,388,909 | 318,819 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $30,849,688 | 278,251 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $31,913,520 | 284,815 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $22,556,292 | 244,195 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $19,666,516 | 234,572 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,915,891 | 202,826 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,896,193 | 203,361 | Shares | Sole | 2025-07-09 | |
| 2023-12-31 | $19,360,336 | 238,987 | Shares | Sole | 2025-07-09 | |
| 2023-09-30 | $17,449,629 | 232,848 | Shares | Sole | 2025-07-09 | |
| 2023-06-30 | $14,353,285 | 186,237 | Shares | Sole | 2025-07-09 | |
| 2023-03-31 | $15,733,435 | 189,628 | Shares | Sole | 2025-07-09 | |
| 2022-12-31 | $5,447,611 | 63,455 | Shares | Sole | 2025-07-09 | |
| 2022-09-30 | $2,440,024 | 39,553 | Shares | Sole | 2025-07-09 | |
| 2022-06-30 | $2,511,834 | 40,638 | Shares | Sole | 2025-07-09 | |
| 2020-12-31 | $2,283,908 | 39,202 | Shares | Sole | 2025-07-08 | |
| 2020-09-30 | $2,477,174 | 39,202 | Shares | Sole | 2025-07-08 | |
| 2020-06-30 | $1,226,269 | 15,938 | Shares | Sole | 2025-07-08 | |
| 2020-03-31 | $1,191,524 | 15,938 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||